Cytokinetics Inc
NASDAQ:CYTK

Watchlist Manager
Cytokinetics Inc Logo
Cytokinetics Inc
NASDAQ:CYTK
Watchlist
Price: 36.625 USD 6.93% Market Closed
Market Cap: 4.4B USD
Have any thoughts about
Cytokinetics Inc?
Write Note

Relative Value

The Relative Value of one CYTK stock under the Base Case scenario is 34.948 USD. Compared to the current market price of 36.625 USD, Cytokinetics Inc is Overvalued by 5%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CYTK Relative Value
Base Case
34.948 USD
Overvaluation 5%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
36
vs Industry
9
Median 3Y
301
Median 5Y
69.3
Industry
7.3
Forward
175.3
vs History
vs Industry
Median 3Y
-10.5
Median 5Y
-11.2
Industry
23.3
Forward
-6.5
vs History
vs Industry
Median 3Y
-14.5
Median 5Y
-14.6
Industry
19.8
vs History
vs Industry
Median 3Y
-22.5
Median 5Y
-23.6
Industry
22.6
vs History
vs Industry
Median 3Y
-15.9
Median 5Y
-9.4
Industry
2.7
vs History
36
vs Industry
7
Median 3Y
277.7
Median 5Y
65
Industry
7.6
Forward
163.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.4
vs History
vs Industry
Median 3Y
-9.8
Median 5Y
-12.3
Industry
4.7
Forward
-6.2
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-12.1
Industry
4.8
Forward
-6.4
vs History
vs Industry
Median 3Y
-13
Median 5Y
-13
Industry
5.3
vs History
vs Industry
Median 3Y
-12.5
Median 5Y
-13.5
Industry
3.8
vs History
60
vs Industry
14
Median 3Y
15.7
Median 5Y
14.2
Industry
5

Multiples Across Competitors

CYTK Competitors Multiples
Cytokinetics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Cytokinetics Inc
NASDAQ:CYTK
4.4B USD 227.2 -7.1 -7.3 -7.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 841 650.5 -160 844.3 -195 316.3 -193 087.6
US
Abbvie Inc
NYSE:ABBV
336.7B USD 5.9 81 15.4 22.8
US
Amgen Inc
NASDAQ:AMGN
159.4B USD 4.7 26.9 14.4 23.8
US
Gilead Sciences Inc
NASDAQ:GILD
141B USD 4.9 23.6 10.3 14.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.1B USD 11.1 -124.5 26.5 27.8
US
Epizyme Inc
F:EPE
94.1B EUR 2 081.7 -531.2 -578.4 -563
AU
CSL Ltd
ASX:CSL
117B AUD 5 27.8 17.2 21.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
59.8B USD 4.2 13.3 11.9 13.3
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.5 -66.3 -59.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41.8B USD 17.8 -155 -695.4 -348.5
P/S Multiple
Revenue Growth P/S to Growth
US
Cytokinetics Inc
NASDAQ:CYTK
Average P/S: 3 076 730.3
227.2
184%
1.2
FR
Pharnext SCA
OTC:PNEXF
33 841 650.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.9
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.9
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
11.1
10%
1.1
US
E
Epizyme Inc
F:EPE
2 081.7
N/A N/A
AU
CSL Ltd
ASX:CSL
5
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.2
4%
1.1
US
S
Seagen Inc
F:SGT
20.1
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.8
29%
0.6
P/E Multiple
Earnings Growth PEG
US
Cytokinetics Inc
NASDAQ:CYTK
Average P/E: 34.5
Negative Multiple: -7.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 844.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.9
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.6
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -124.5 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.2 N/A N/A
AU
CSL Ltd
ASX:CSL
27.8
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.3
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.5 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -155 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Cytokinetics Inc
NASDAQ:CYTK
Average EV/EBITDA: 15.9
Negative Multiple: -7.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 316.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.4
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10.3
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.5
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.4 N/A N/A
AU
CSL Ltd
ASX:CSL
17.2
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.9
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -695.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Cytokinetics Inc
NASDAQ:CYTK
Average EV/EBIT: 20.6
Negative Multiple: -7.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 087.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.8
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
14.1
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.8
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563 N/A N/A
AU
CSL Ltd
ASX:CSL
21.5
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.3
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.8 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -348.5 N/A N/A